Elite medical facilities ban commercial support of CME

November 1, 2008 Diagnostic Imaging. Vol. 30 No. 11 Elite medical facilities ban commercial support of CME Restrictions for drug and device companies attempt to eliminate conflicts of interest in programs Stanford University has joined other high-profile medical schools and research institutions in severely restricting funding from pharmaceutical and device companies for continuing medical education programs—including programs for radiologists and radiology technologists. Under the new Stanford policy, announced in August, all contributions for CME from medical industry will be funneled through a central office. Pharmaceutical or device companies will not be allowed to earmark funds for programs on specific subjects. Commercial support for CME can be provided only in broad areas, such as medical, pediatric, and surgical specialties or diagnostic and imaging technologies. Device or pharmaceutical companies can no longer sponsor exhibits, receptions, briefings, or training sessions in tandem with Stanford CME events.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC